Mia M. Gaudet
Mia M. Gaudet is a renowned epidemiologist and biostatistician known for her significant contributions to the field of cancer epidemiology. She is currently serving as the Strategic Director of Breast and Gynecologic Cancer Research at the American Cancer Society.
Early Life and Education[edit | edit source]
Mia M. Gaudet was born and raised in United States. She completed her undergraduate studies in biology and mathematics from the University of Vermont. She then pursued her Master's degree in Public Health from the University of Massachusetts. Gaudet furthered her education by obtaining a Ph.D. in Epidemiology from the University of Pittsburgh.
Career[edit | edit source]
Gaudet started her career as a research scientist at the National Cancer Institute. Her work primarily focused on the genetic and environmental risk factors for breast and ovarian cancers. She later joined the American Cancer Society where she currently oversees the organization's research on breast and gynecologic cancers.
Research and Contributions[edit | edit source]
Gaudet's research has significantly contributed to the understanding of the genetic and environmental risk factors for breast and ovarian cancers. Her work has led to the identification of several novel genes associated with these cancers. She has also been involved in large-scale genome-wide association studies (GWAS) that have furthered the understanding of the genetic architecture of these cancers.
Awards and Recognition[edit | edit source]
Gaudet's work has been recognized by several prestigious awards. She is a recipient of the National Institutes of Health (NIH) Merit Award for her contributions to cancer epidemiology.
Publications[edit | edit source]
Gaudet has authored and co-authored numerous scientific publications in high-impact peer-reviewed journals. Her work has been widely cited, reflecting the significant impact of her research in the field of cancer epidemiology.
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD